Outcomes of a new dosage regimen of amikacin based on pharmacokinetic parameters of Korean neonates

Abstract

A new amikacin dosing regimen based on the pharmacokinetic parameters of Korean neonates was effective in achieving peak and trough amikacin concentrations within the target range.